Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HIV eradication--from Berlin to Boston.

Literature DB >> 24714473

HIV eradication--from Berlin to Boston.

Paula M Cannon¹, Donald B Kohn², Hans-Peter Kiem³.

Abstract

Mesh：

Substances：
Anti-Retroviral Agents

Year: 2014 PMID： 24714473 DOI： 10.1038/nbt.2868

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

13 in total

1. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors: D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal: Nat Med Date: 1999-05 Impact factor: 53.440

2. Absence of detectable HIV-1 viremia after treatment cessation in an infant.

Authors: Deborah Persaud; Hannah Gay; Carrie Ziemniak; Ya Hui Chen; Michael Piatak; Tae-Wook Chun; Matthew Strain; Douglas Richman; Katherine Luzuriaga
Journal: N Engl J Med Date: 2013-10-23 Impact factor: 91.245

3. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

Authors: Kristina Allers; Gero Hütter; Jörg Hofmann; Christoph Loddenkemper; Kathrin Rieger; Eckhard Thiel; Thomas Schneider
Journal: Blood Date: 2010-12-08 Impact factor: 22.113

Review 4. Chemokine receptor 5 knockout strategies.

Authors: Paula Cannon; Carl June
Journal: Curr Opin HIV AIDS Date: 2011-01 Impact factor: 4.283

Review 5. Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors: Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal: Immunol Rev Date: 2013-07 Impact factor: 12.988

6. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors: Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal: N Engl J Med Date: 2014-03-06 Impact factor: 91.245

Review 7. Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies.

Authors: E H Warren; H J Deeg
Journal: Tissue Antigens Date: 2013-04

8. CCR5 as a natural and modulated target for inhibition of HIV.

Authors: Bryan P Burke; Maureen P Boyd; Helen Impey; Louis R Breton; Jeffrey S Bartlett; Geoff P Symonds; Gero Hütter
Journal: Viruses Date: 2013-12-30 Impact factor: 5.048

9. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

Authors: Steven A Yukl; Eli Boritz; Michael Busch; Christopher Bentsen; Tae-Wook Chun; Daniel Douek; Evelyn Eisele; Ashley Haase; Ya-Chi Ho; Gero Hütter; J Shawn Justement; Sheila Keating; Tzong-Hae Lee; Peilin Li; Danielle Murray; Sarah Palmer; Christopher Pilcher; Satish Pillai; Richard W Price; Meghan Rothenberger; Timothy Schacker; Janet Siliciano; Robert Siliciano; Elizabeth Sinclair; Matt Strain; Joseph Wong; Douglas Richman; Steven G Deeks
Journal: PLoS Pathog Date: 2013-05-09 Impact factor: 6.823

10. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.

Authors: Lijing Li; Ludmila Krymskaya; Jianbin Wang; Jill Henley; Anitha Rao; Lan-Feng Cao; Chy-Anh Tran; Monica Torres-Coronado; Agnes Gardner; Nancy Gonzalez; Kenneth Kim; Pei-Qi Liu; Ursula Hofer; Evan Lopez; Philip D Gregory; Qing Liu; Michael C Holmes; Paula M Cannon; John A Zaia; David L DiGiusto
Journal: Mol Ther Date: 2013-04-16 Impact factor: 11.454

8 in total

HIV eradication--from Berlin to Boston.

1. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

2. Absence of detectable HIV-1 viremia after treatment cessation in an infant.

3. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

Review 4. Chemokine receptor 5 knockout strategies.

Review 5. Immune activation and HIV persistence: implications for curative approaches to HIV infection.

6. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Review 7. Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies.

8. CCR5 as a natural and modulated target for inhibition of HIV.

9. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

10. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.

1. A novel anti-HIV immunotherapy to cure HIV.

Review 2. HIV Eradication Strategies: Implications for the Central Nervous System.

Review 3. The clinical applications of genome editing in HIV.

Review 4. HIV Diagnosis and Treatment through Advanced Technologies.

Review 5. Immunologic strategies for HIV-1 remission and eradication.

Review 6. Is the central nervous system a reservoir of HIV-1?

Review 7. Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.

Review 8. Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?